Axonics, Inc. short interest in 2022
In 2022, Axonics, Inc.'s disclosed short interest ran from 9.75% of shares outstanding on 14 Jan 2022 to 7.37% on 30 Dec 2022, a change of -2.38 percentage points. The year's high was 9.75% on 14 Jan 2022 and its low 6.47% on 15 Nov 2022, averaging 8.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.98 days on 15 Feb 2022. Full history: Axonics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2022 in figures
- Start of year
- 9.75% (14 Jan 2022)
- End of year
- 7.37% (30 Dec 2022)
- Change
- -2.38 pp
- High
- 9.75% (14 Jan 2022)
- Low
- 6.47% (15 Nov 2022)
- Average
- 8.49%
- Highest days to cover
- 11.98 (15 Feb 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 9.75% | 8.26 | results (8-K) |
| 31 Jan 2022 | 8.79% | 8.62 | |
| 15 Feb 2022 | 9.40% | 11.98 | |
| 28 Feb 2022 | 8.93% | 7.36 | results (8-K) |
| 15 Mar 2022 | 9.14% | 9.33 | 10-K filed |
| 31 Mar 2022 | 8.94% | 10.06 | |
| 14 Apr 2022 | 9.22% | 10.13 | |
| 29 Apr 2022 | 9.35% | 9.16 | |
| 13 May 2022 | 9.21% | 4.58 | 10-Q filed, results (8-K) |
| 31 May 2022 | 9.27% | 9.97 | |
| 15 Jun 2022 | 9.49% | 10.31 | |
| 30 Jun 2022 | 8.98% | 7.08 | |
| 15 Jul 2022 | 8.91% | 8.47 | |
| 29 Jul 2022 | 8.63% | 8.08 | |
| 15 Aug 2022 | 8.65% | 4.06 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 9.12% | 8.13 | |
| 15 Sep 2022 | 8.52% | 5.22 | |
| 30 Sep 2022 | 7.88% | 6.29 | |
| 14 Oct 2022 | 7.67% | 6.35 | |
| 31 Oct 2022 | 7.02% | 5.18 | results (8-K) |
| 15 Nov 2022 | 6.47% | 4.80 | 10-Q filed |
| 30 Nov 2022 | 6.47% | 8.28 | |
| 15 Dec 2022 | 6.49% | 5.25 | |
| 30 Dec 2022 | 7.37% | 6.44 |
See also: Axonics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.